The 14 warning letters to online marketers FDA announced April 25 to remind consumers to be suspicious about cancer treatment claims for products available without prescriptions also could be reminders about the agency's challenge in regulating the consumer health space.
The warnings FDA's Office of Regulatory Affairs submitted earlier April 17 to US firms were generated from a collaboration by...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?